You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 4,749,570


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,749,570
Title: Targeting conjugates of albumin and therapeutic agents
Abstract:The invention provides a conjugate comprising an enzyme having its antigenic sites or antigenicity masked by albumin and having a targeting agent attached, and a method for its preparation. The albumin is included in an amount sufficient to mask antigenicity of the enzyme. The targeting agent used has binding specificity for receptor sites on cells towards which it is desirable to direct the enzyme. Insulin, immunoglobulin G, antibody against human pancreatic tumor cell, and antibody against hyaluronic acid are exemplified as targeting agents.
Inventor(s): Poznansky; Mark J. (Alberta, CA)
Assignee: The Governors of the University of Alberta (Edmonton, CA)
Application Number:06/815,752
Patent Claims:1. A water soluble, sterile and non-immunogenic composition of matter, comprising an enzyme selected from the group consisting of .alpha.-1,4-glucosidase, L-asparaginase, and superoxide dismutase, said enzyme chemically linked to homologous albumin, and a targeting agent chemically linked to the albumin, the amount of albumin being sufficient to mask antigenicity of the enzyme, and the targeting agent having binding specificity for receptor sites on cells to which it is desirable to direct the enzyme.

2. The composition as set forth in claim 1, wherein the targeting agent is selected from the group consisting of serum hormones and cell specific antibodies.

3. The composition as set forth in claim 1, wherein the targeting agent is insulin.

4. The composition as set forth in claim 1, wherein the targeting agent is an antibody directed against human pancreatic tumor cells.

5. The composition as set forth in claim 1, wherein the targeting agent is an immunoglobulin.

6. The composition as set forth in claim 1, wherein the targeting agent is the (Fab').sub.2 fragment of an immunoglobulin G molecule.

7. The composition as set forth in claim 3, wherein the enzyme is selected from the group consisting of .alpha.-1,4-glucosidase and L-asparaginase.

8. The composition as set forth in claim 4, wherein the enzyme is L-asparaginase.

9. The composition as set forth in claim 5, wherein the enzyme is selected from the group consisting of .alpha.-1,4-glucosidase and L-asparaginase.

10. The composition as set forth in claim 6, wherein the enzyme is selected from the group consisting of .alpha.-1,4-glucosidase and L-asparaginase.

11. The composition as set forth in claim 1, wherein the targeting agent is an antibody against hyaluronic acid, and the enzyme is superoxide dismutase.

Details for Patent 4,749,570

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 01/10/1978 ⤷  Try a Trial 2005-06-07
Octapharma Pharmazeutika Produktionsges.m.b.h. CUTAQUIG immune globulin subcutaneous (human)-hipp Solution 125668 12/12/2018 ⤷  Try a Trial 2005-06-07
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.